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Iron supplementa b s t r a c t
We have taken a vital step towards understanding why probiotic bacteria increase iron absorption in the
gastrointestinal tract. We show here that Lactobacillus fermentum, one of the main probiotics of the
microbiota, exhibits an extraordinary ferric-reducing activity. This activity is predominantly due to an
excreted molecule: p-hydroxyphenyllactic acid (HPLA). Reduction of Fe(III) to Fe(II) is essential for iron
absorption in the gastrointestinal tract. By reducing Fe(III), HPLA boosts Fe(II) absorption through the
DMT1 channels of enterocytes. An in vitro experiment tested and confirmed this hypothesis. This discov-
ery opens new avenues for the treatment of iron deficiency in humans, one of the most common and
widespread nutritional disorders in the world.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Iron is an indispensable element for humans due to its involve-
ment in essential biochemical processes, including energy
production, biosynthesis, replication, and locomotion (Crichton,
2001; Silva & Faustino, 2015). Iron deficiency is the most common
and widespread nutritional disorder in the world. Besides affecting
many children and women in developing countries, it is the only
nutrient deficiency prevalent in industrialized countries. The
human body receives iron from food. Though the daily require-
ment is 20–25 mg, no more than 2 mg are really absorbed (Milto,
Suhodolo, Prokopieva, & Klimenteva, 2016). Adequate iron levels
in the blood are partially maintained by recycling the iron released
upon the degradation of iron-containing proteins, especially
hemoglobin.
Heme-iron, present in hemoglobin and myoglobin, has high
bioavailability (Huch & Schaefer, 2006); however, the majority of
iron in food (>90%) is in non-heme forms, either as free iron or
bound to low molecular-weight biomolecules (Crichton,
Danielson, & Geisser, 2008). Iron from food is mainly absorbed
by the duodenum enterocytes (90%). The stomach does not play
a significant role in the assimilation of iron, as its absorption is
no more than 2% of the total (Shayeghi et al., 2005).Iron transfer through the enterocyte membrane occurs by the
combined activities of two proteins: DMT1 and DcytB. The coupled
work of DcytB/DTM1 is required for iron absorption since iron
enters the small intestine lumen mainly as Fe(III), the result of
Fe(II) oxidation by gastric juice components. Free Fe(III) is not able
to enter into the enterocyte and must be reduced (Lane, Bae,
Merlot, Sahni, & Richardson, 2015; McKie, 2008). The iron-
regulated ferrireductase protein, DcytB, is highly expressed at
duodenal enterocytes and reduces Fe(III) to Fe(II). Upon reduction,
Fe(II) is transferred across the apical membrane of enterocytes by
divalent metal transporters, mainly DMT1. Once inside the entero-
cytes, Fe(II) can be used for synthesis of iron-containing proteins,
transported to plasma by the membrane protein ferroportin, or
stored inside ferritin for later use when needed by cells (Lane
et al., 2015; McKie, 2008).
Interestingly, the bioavailability of iron is influenced by a series
of chemical species in the gastrointestinal tract. Whereas oxalates,
phytates, phenolates and phosphates suppress iron absorption,
ascorbic and citric acids, increase it (Conrad & Umbreit, 2002).
For this reason commercial iron supplements are usually accom-
panied by ascorbic or citric acid. Strategies to increase the
intake of iron-rich foods, as well as dietary factors that enhance
iron absorption, are therefore extremely important for human
health.
Probiotic bacteria constitute an important part of natural
microbiota. Bacteria produce many different metabolic substances
that can act as antioxidants, bioflocculants or even immune
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Backhed, 2013). They survive the harsh stomach conditions and
nest in different areas of intestines. Though the European Food
Safety Authority (EFSA) has recently concluded that there is
insufficient evidence to claim that a probiotic can help boost iron
absorption (EFSA, 2016), other studies have shown that the probi-
otic bacteria of the human gut microbiota facilitate iron absorption
(Bering, Suchdev, & Sjoltov, 2006; Hoppe, Onning, Berggren, &
Hulthen, 2015; Perez-Conesa, Lopez, & Ros, 2007). For example, it
has been observed that the amount of probiotic bacteria in gut
flora is significantly lower in anemic patients than in healthy
people.
The mechanisms of this influence are not entirely understood.
As of yet no compound excreted by bacteria has been shown to
be related to iron absorption. Some have proposed that bacterial
fermentation in intestines decreases the pH due to the production
of lactic acid, which can increase iron solubility, leading to higher
iron absorption (Hoppe et al., 2015). No published study has
evaluated the effect of the ferric-reducing activity of probiotic
bacteria on iron absorption. We show that Lactobacillus fermentum,
one of the main components of the microbiota, exhibits
considerable extracellular ferric-reducing activity. We have isolated
and identified the excreted molecule that produces the ferric-
reducing activity of Lactobacillus fermentum: p-hydroxyphenyllactic
acid (HPLA). This molecule efficiently reduces Fe(III) to Fe(II) at
acidic pH.
From the results described here, we propose that the increase of
iron absorption in humans, due to the presence of probiotic bacte-
ria in gut flora, could be related, not only to the decrease of pH
caused by these lactic acid bacteria (Hoppe et al., 2015), but also
to the ferric-reducing activity of the excreted HPLA. We have per-
formed an in vitro experiment on iron uptake by enterocytes to
confirm that HPLA promotes iron absorption. These results shed
light on the reason why probiotic bacteria increase iron absorption
in humans and can lead to more efficient strategies to increase iron
absorption in humans.2. Materials and methods
2.1. Lactobacillus fermentum culture
L. fermentum CECT5716 was grown in anaerobic conditions in a
synthetic medium at 37 C with orbital agitation for 24 h at an ini-
tial concentration of 1 mg of bacteria per ml of medium. The syn-
thetic medium consisted of (g l1) Na2HPO4 – 5.0, KH2PO4 – 6.0,
trisammonium citrate – 2.0, sucrose – 50.0, MgSO4 – 1.0 and trace
elements solution – 10 ml (consisting of (g l1): MnSO4 – 2.0, CoCl2
– 1.0, ZnCl2 – 1.0 dissolved in 0.1 N HCl solution). The mediumwith
an initial pH 6.7 was sterilized at 121 C. The final L. fermentum cell
concentration was 3.3  108 CFU ml1.2.2. Ferric-reducing activity of L. fermentum
1 ml of bacterial culture was mixed with 3.6 ll of a 10 mM Fe
(NO3)39H2O water solution and 7 ll of a 70 mM 3-(2-pyridiyl)-5,
6-diphenyl-1,2,4-triazine-p,p0-disulfonic acid monosodium salt
hydrate (ferrozine, fz) water solution and the resulting mixture
was incubated for 6 and 24 h and then centrifuged. The ferric-
reducing capacity of L. fermentum was measured by UV–vis spec-
troscopy through the apparition of a band centred at 562 nm due
to the formation of the complex [FeII(fz)3] (e562 = 27,900 M1). A
control of the ferric-reducing activity of the culture media, without
bacteria, showed no UV–vis band at 562 nm. Similar ferric-
reducing activity was exhibited by the corresponding supernatant
solution (1 ml) from the bacterial culture.2.3. Isolation of excreted bacterial compound/s with ferric-reducing
activity
Bacteria were removed by centrifugation at 3000g for 10 min
and then the supernatant was filtered, using EMD Millipore Steri-
topTM Sterile Vacuum Bottle-Top Filters. 2 l of the filtered super-
natant solution were subjected to solid-phase extraction on a
column packed with SP-207ss brominated polystyrenic resin
(65 g to render a column bed of 3.5 cm diameter and 11 cm height)
previously equilibrated with water. The column was washed with
water (1 l) and afterwards eluted with 200 ml of methanol. The sol-
vent was evaporated under a nitrogen stream and the resulting
extract dissolved in 500 ll of DMSO and further purified by
reversed phase semi-preparative HPLC (Agilent Zorbax SB-C8,
9.4  250 mm, 7 lm; 3.6 ml/min, UV detection at 210 and
280 nm) with a linear gradient of water-CH3CN (5%–50%) over
40 min to yield 80 fractions of 1.8 ml. The ferric-reducing activity
of each fraction was tested, using a 96-well microtitre plate con-
taining 2 ll of each fraction diluted with 198 ll of water. 1.08 ll
of a 10 mM Fe(NO3)3 stock solution and 2.1 ll of a 70 mM fz stock
solution were added to each well. The presence of the complex
[FeII(fz)3], determined by measuring the absorbance at 570 nm,
using a microplate reader (Envision 2104 multilabel reader. Perkin
Elmer), was detected only in fractions 8–11. These fractions
were pooled, evaporated and then dissolved in 1 ml of distilled
water. The resulting water solution was further purified by
reversed phase semi-preparative HPLC (Waters Atlantis C18,
9.4  250 mm, 7 lm; 3.6 ml/min, UV detection at 210 and
280 nm) with a linear gradient of water-CH3CN (0–25%) over
40 min to yield 80 fractions of 1.8 ml. The ferric-reducing activity
of these fractions was tested as before. Only fractions 28 and 29
exhibited ferric-reducing activity. These fractions were pooled,
evaporated and analyzed by LC–ESI-TOFMS and NMR spectroscopy.
2.4. Structure elucidation of the excreted bacterial compound with
ferric-reducing activity
For NMR analysis, the sample (pooled dry fractions or the HPLA
standard) was dissolved in deuterated methanol, CD3OD. NMR
spectra, including 1H, COSY, HSQC and HMBC, were recorded on
a Bruker Avance III spectrometer (500 and 125 MHz for 1H and
13C NMR, respectively) equipped with a 1.7 mm TCI MicroCryo-
ProbeTM, using the signal of the residual deuterated solvent as
internal reference (dH 3.31 and dC 49.0 ppm). LC–DAD-ESI-HRMS
analysis of an aliquot of the final pooled fractions was performed
on an Agilent 1200 rapid resolution HPLC system hyphenated with
a Bruker maXis QTOF mass spectrometer, using a Zorbax SB-C8 col-
umn (2.1  30 mm, 5 lm), maintained at 40 C and with a flow
rate of 300 ll min1. Solvent A consisted of 10% acetronitrile and
90% water with 1.3 mM trifluoroacetic acid and ammonium for-
mate, and solvent B was 90% acetronitrile and 10% water with
1.3 mM trifluoroacetic acid and ammonium formate. The gradient
started at 10% B and went to 100% B in 6 min, kept at 100% B for
2 min and returned to 10% B for 2 min to initialize the system. Full
diode array UV scans from 100 to 900 nm were collected in 4 nm
steps at 0.25 s/scan. The mass spectrometer was operated in posi-
tive ESI mode. The instrumental parameters were: 4 kV capillary
voltage, drying gas flow of 11 l min1 at 200 C, nebulizer pressure
at 2.8 bars. TFA-Na cluster ions were used for mass calibration of
the instrument prior to sample injection. Pre-run calibration was
by infusion with the same TFA-Na calibrant. The structure of the
target compound was established, using the NMR data. Its molec-
ular formula was corroborated by the HRMS results. Further confir-
mation on the identity was obtained by direct comparison with the
1H and HSQC NMR spectra of an HPLA standard prepared in CD3OD.
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Fig. 1. Ferric-reducing activity of L. Fermentum (black line) and the supernatant
liquid (grey line) after 6 (dashed lines) and 24 h (solid lines). Development of the
UV–vis band centered at 562 nm due to [FeII(fz)3] informs of the ferric-reducing
activity.
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excreted compound responsible for such reducing power displayed
by the L. fermentum culture.
2.5. Ferric-reducing activity of HPLA vs pH
Racemic HPLA was acquired from Sigma-Aldrich. Solutions of
HPLA (144 lM) were prepared in different buffers with pH ranging
from 3.0 to 7.4 and mixed with solutions of 10 mM Fe(NO3)39H2O
and 70 mM of fz. Ferric-reducing activity of HPLA at these different
pH values was measured by UV–vis spectroscopy through the
appearance of a band centred at 562 nm, due the formation of
the complex [FeII(fz)3] (e562 = 27,900 M1). The results showed that
HPLA exhibits high ferric-reducing activity only at low pH.
2.6. Ferric-reducing activity of L. fermentum after HPLA addition
The ferric-reducing capacity of L. fermentum was measured, as
indicated above, after incubation for 6 and 24 h. HPLA (3.6 lM)
was added to the supernatant obtained after centrifugation of the
6 h culture and the ferric-reducing activity of the resulting mixture
was measured. The ferric-reducing activity of HPLA (3.6 lM) in the
medium grown was used as control.
2.7. Ferric-reducing activity of HPLA versus lactic acid (LA),
p-methylphenol (p-mPh) and the mixture p-methylphenol and lactic
acid (LA + p-mPh)
Two different experimental conditions were assayed, excess
and deficiency of Fe(III) with respect to the reducing molecules.
The ferric-reducing activity was referred to the initial concentra-
tions of Fe(III) or the chemical reductant, respectively.
A 50 mM stock solution of HPLA was prepared by dissolving
9.1 mg in 1 ml of Mili-Q water. Solutions of LA and p-mPh at the
same 50 mM concentration were prepared, as well as a mixture
solution of both (LA + p-mPh) containing 50 mM of each reducing
molecule. Lactic acid and p-methylphenol were also purchased
from Sigma-Aldrich.
110 ll of each stock solution were added to 879 ll of Mili-Q
water containing 3.6 ll of a 10 mM solution of Fe(NO3)39H2O
and 7 ll of a ferrozine solution (70 mM). The p-methylphenol
and lactic acid mixture was preparing by adding 110 ll of the
p-methylphenol stock solution and 110 ll of the lactic acid stock
solution to 769 ll of Mili-Q water containing 3.6 ll of a 10 mM
Fe(NO3)39H2O solution and 7 l of a 70 mM fz solution. The final
concentrations of the reducing molecules and Fe(III) were
5.5 mM and 36 lM. The ferric-reducing activity of each sample
was determined at 0, 2, 4 and 24 h by monitoring the UV–vis band
at 562 nm of the complex [[FeII(fz)3]. In a second experiment a
25 lM concentration of each reducing molecule was used.
2.8. In vitro experiment on iron internalization in enterocyte cells
IEC6 epithelial rat small intestine cells were provided by the
Scientific Instrumentation Centre (University of Granada, Spain).
Cell line was grown adherently and maintained in DMEM + 2 mM
glutamine + 0.1 IU/ml of insulin + 5% of foetal bovine serum (FBS)
at 37 C in 5% CO2. All experiments were performed in 12-well
plates. Cells were seeded onto the plates at a density of 5  104
cells per well and incubated for 48 h prior to the experiments.
The wells were filled up to a final volume of 1 ml with a water
solution of Fe(NO3)39H2O (360 lM), the grown medium and HPLA,
at two different concentrations, 360 and 36 lM. Two more wells
with a blank sample containing only cells were also prepared.
Plates were incubated at 37 C for 0.5 or 5 h. Samples were filtered,using a 0.2 lm Minisart RC filter and the total iron concentration
(Fe(II) and Fe(III)) measured by ICP-OES.
2.9. Statistical analysis
The ferric-reducing activity of HPLA versus LA, p-mPh and the
mixture LA + p-mPh and the in vitro experiment on iron internal-
ization in enterocyte cells were conducted in triplicates. Descrip-
tive error bars represent the standard deviation (SD) of the
triplicates and it was calculated using the n  1 method.
3. Results and discussion
3.1. Lactobacillus fermentum shows a high ferric-reducing activity
The ability to reduce Fe(III) to Fe(II) is usually related to the
antioxidant properties of a chemical species. In the context of iron
metabolism, this redox reaction is essential for iron absorption
since non-heme iron is usually in the form of Fe(III), which cannot
be absorbed by enterocytes until it has been reduced to Fe(II).
The ferric-reducing activity of L. fermentum was measured
through its incubation with Fe(III) and ferrozine by monitoring
the formation of the Fe(II) complex with the chelator, [FeII(fz)3],
through the appearance and increase of its characteristic UV–vis
band at 562 nm. The supernatant liquid isolated after centrifuga-
tion of the bacteria exhibits activity similar to that of the bacterial
broth after 6 and 24 h (Fig. 1). This evidence indicates that the
ferric-reducing ability of L. fermentum is due to the molecule(s)
excreted by the bacteria, However, the patterns of ferric-reducing
activity of the supernatant and the bacterial culture differ.
Whereas the former is able to reduce a specific amount of Fe(III)
and then is rendered inactive, the latter exhibits prolonged activity.
The bacterial culture can reduce additional amounts of Fe(III) after
reducing the same amount of Fe(III) as reduced by the supernatant.
This could be explained if the bacterium continuously excreted or
regenerated the molecule responsible for its ferric-reducing
activity.
The characterization of excreted active molecules by living
organisms is of great interest in the biomedical field. In fact, some
of these molecules are in the pharmaceutical market for different
medical purposes. We addressed the challenge of isolating and
characterizing the molecule responsible for the ferric-reducing
activity of L. fermentum because no such study has been thus far
done.
An assay-guided fractionation approach was implemented.
First, an extract of the culture supernatant was prepared. A bromi-
nated polystyrenic resin (SP207ss), with the capacity to retain both
Chart 1. Chemical structure of p-hydroxyphenyllactic acid HPLA.
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After confirming the ferric-reducing activity of the extract obtained
by elution from the resin with methanol, the extract was subjected
to semipreparative HPLC fractionation. After passing through a C8
reversed-phase column, the fractions with the reducing ability
were pooled and further fractionated with a C18 column. The
two fractions showing ferric-reducing activity were pooled and
analyzed by NMR and LC-DAD-ESI-TOFMS. The 1H NMR spectrum
(Fig. 2) revealed a mixture of a few compounds. The signals of a
para-hydroxyphenyl group, corresponding to one of the major
components, could easily be identified. Additional 2D NMR exper-
iments, including COSY, HSQC and HMBC (Supporting information
S1–S8), were employed to elucidate the connectivity of the
compound containing this structural moiety, which turned out to
correspond to p-hydroxyphenyllactic acid (HPLA, Chart 1).
The molecular formula of HPLA, C9H10O4, was a major compo-
nent detected in the corresponding LC–HRMS analysis (Supporting
information S9).
Further confirmation of the identity of the compound was
obtained by direct comparison of the NMR spectra of the final
pooled active fractions with the spectrum of a commercial HPLA
standard (Fig. 2). When the standard was evaluated for its ferric-
reducing activity, it showed the same reducing power. Thus, HPLA
is the compound excreted by L. fermentum, responsible for the bac-
terial ferric-reducing activity.
Interestingly, HPLA has already been identified as an antioxi-
dant compound, in a radical-scavenging assay, produced by the
sister species Lactobacillus plantarum (Suzuki et al., 2013). The pro-
duction of HPLA by lactic acid bacteria (LAB) was first reported
from L. plantarum 21B (Lavermicocca et al., 2000). This compound
has shown antifungal activity and contributes to the biopreserva-
tive properties claimed for LAB (Crowley, Mahonya, & Sinderen,
2013). HPLA has been isolated as its L-enantiomer in L. plantarum
(Suzuki et al., 2013). The same chirality is expected for the HPLA
produced by the L. fermentum strain employed in this work, assum-
ing a common pathway for HPLA production among lactobacilli.
The biosynthesis of HPLA in LAB likewise explains the apparent
regeneration of the ferric-reducing activity observed for L. fermen-
tum in reduction experiments with increasing amounts of Fe(III). In
these bacteria, tyrosine is transformed by transamination into
4-hydroxyphenylpyruvate, which is further reduced to HPLA by a
hydroxyacid dehydrogenase (Lavermicocca et al., 2000; Li, Jiang,
& Pan, 2007; Valerio, Lavermicocca, Pascale, & Visconti, 2004).Fig. 2. 1H NMR spectra (500 MHz, CD3OD) of the final pooled fractions displaying ferricTransamination is the rate-limiting step in such biosynthesis. It
has been demonstrated that HPLA production dramatically
increases in fermentations of Lactobacillus sp. SK007 supplemented
with 4-hydroxyphenylpyruvate (tyrosine as supplement renders
just a moderate increase in production) (Mu, Yang, Jia, Zhang, &
Jiang, 2010). These results indicate that the bacterium is very
efficient in reducing 4-hydroxyphenylpyruvate to HPLA. Such
efficiency would help to recycle the HPLA consumed in the
reduction of Fe(III). In this ferrireduction HPLA gets oxidized to
4-hydroxyphenylpyruvate which would get back to HPLA via the
corresponding Lactobacillus hydroxyacid dehydrogenase, that
way explaining the apparent regeneration of the ferric-reducing
activity already mentioned.
Once HPLA was identified as the molecule responsible for the
ferric-reducing activity of L. fermentum, a study of its ability to
reduce Fe(III) to Fe(II) as a function of pHwas carried out. As shown
in Fig. 3, HPLA exhibits a ferric-reducing activity extremely depen-
dent on pH. At pH above 6, HPLA hardly reduces Fe(III) to Fe(II) but,
at pH 3.8, this reduction is practically complete.
To further verify that HPLA is the principal factor in the ferric-
reducing activity of L. fermentum, we performed an experiment in
which HPLA was directly added to a 6 h bacterial culture. The
resulting ferric-reducing activity of the mixture was compared to
that of the 24 h bacterial culture. As shown in Fig. 4, the addition
of HPLA to the culture media leads to an increase in the ferric-
reducing activity (Fig. 4, green bar). The activity of this mixture
is close to the sum of that of L. fermentum (Fig. 4, blue bar) and
the HPLA control (Fig. 4, red bar). Likewise, the addition of HPLA
to the 6 h culture medium gives rise to a ferric-reducing activity
close to that of the 24 h culture medium, indicating that HPLA is
continuously excreted during the bacterial growth from 6 to 24 h
and that this molecule is responsible for the ferric-reducing activ-
ity of L. fermentum.
Interestingly, HPLA seems to be a specific reductant of Fe(III). It






Fig. 4. Ferric-reducing activity, as a percentage of Fe(III) reduction, of a 6 and 24 h
culture L. fermentum (black), the addition of HPLA (3,6 lM) to the culture medium











Fig. 3. Ferric-reducing activity of HPLA at different pHs and buffers. The % of Fe(III)
reduction was calculated as the ratio between concentrations of [FeII(fz)3] and the
initial Fe(III).
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presence of L. fermentum (Carmona, Martin, Galvez, & Dominguez-
Vera, 2014; González, Gálvez, Clemente-León, & Domínguez-Vera,
2015). This result indicates that the chemical reducing mechanism
of L. fermentum does not solely contain HPLA but also other reducing
molecules. Our work has reached a milestone in unravelling such a
reducing mechanism after having being able to identify one of the
molecules excreted by L. fermentum and label its functionality for
future applications.
The characterization of HPLA as the main agent of the pH-
dependent ferric-reducing activity of L. fermentum and its strong
reducing ability dependence on pH, provokes us to hypothesise
that excreted HPLA could reduce Fe(III) under acid stomach condi-
tions and facilitate Fe(II) absorption in the duodenum, as occurs for
ascorbic and citric acids. Related studies report that low molecular
weight fractions exhibiting ferric-reducing activity in human
milk enhance iron absorption in newborns (Pullakhandama,
Krishnapillai, Kasulab, Kilaria, & Thippandea, 2008).
HPLA contains two chemical moieties with potential reducing
Fe(III) activity: the terminal lactic acid and the phenol group. To
get insight into the mechanism of the ferric-reducing activity of
HPLA, we compared the HPLA ability to reduce Fe(III) at acidic
pH with that of its pure chemical moieties, namely lactic acid
(LA) and p-methylphenol (p-mPh), and the mixture of both(LA + p-mPh). Both an excess of reducing molecules with respect
to Fe(III) and a slight excess of Fe(III) with respect to the active
molecules were examined. The first was to understand the kinetics
of Fe(III) reduction and the second was to evaluate the ferric-
reducing activity of the individual chemical moieties.
The most interesting result of these experiments is that HPLA
reduces Fe(III) to the same extent as the mixture of lactic acid
and p-mPh, practically doubling the reducing capacity of separated
LA and p-mPh (Fig. 5). Thus, both HPLA chemical moieties are
effective for Fe(III) reduction and exhibit ferric-reducing activity.
When the experiment was done in excess of Fe(III) towards the
reducing molecules, the ferric-reducing activity vs. time revealed
that HPLA seems to reduce Fe(III), first by the LA moiety and then
by p-mPh (Fig. 5A). Fe(III) reduction versus time shows that the
reduction by HPLA follows the same pattern as LA in the initial
steps. The%Fe(III) reduction was about 20% by HPLA and 15% by
LA after 2 h, whereas that of p-mPh was 90%. This indicates that
pure p-mPh has faster Fe(III) reduction mechanisms than LA and
HPLA. However, over a prolonged period of time (24 h), the %
Fe(III) reductions of HPLA, p-mPh, and the mixture, LA  p-mPh,
are similar and close to 100%, whereas that of LA is about 80%.
In the second experiment, Fe(III) was in excess with respect to
the reducing molecules. The results clearly indicate that the
capacity of HPLA to reduce Fe(III) is double than that of LA and
of p-mPh and is close to the capacity of the mixture of both
(Fig. 5B). Therefore, the combination of both chemical moieties
(lactic acid and phenol) makes HPLA an extraordinary Fe(III) reduc-
ing molecule.
An in vitro experiment of iron uptake by enterocytes in the pres-
ence of HPLA was performed to test whether HPLA could be related
to the effect on iron absorption by probiotic bacteria, (Fig. 6). HPLA
was incubated at two concentrations (36 and 360 lM)with entero-
cytes (IEC-6 cells) in the presence of Fe(III). L. fermentum, and its
supernatant liquid obtained after bacterial centrifugation, were
also incubated with IEC-6 enterocytes and Fe(III). The concentra-
tion of total iron (Fe(II) and Fe(III)) of the solutions was measured
at two different times (30 and 300 min), by ICP-OES, to evaluate
the amount of iron internalized into the cells.
The first conclusion drawn from these data is that L. fermentum
and its supernatant liquid significantly increased iron absorption
by enterocytes. Values for Fe(III) absorption after incubation with
enterocytes are very close to initial values, meaning that entero-
cytes hardly absorb Fe(III) (Fig. 6). In contrast, both enterocytes
with L. fermentum and enterocytes with the supernatant (the
excreted molecules) reduce iron concentrations to less than half
those of the controls. Thus, the bacteria and excreted molecules
facilitate enterocyte iron uptake. Moreover, enterocyte iron
absorption by bacteria and by supernatant liquid obtained after
centrifugation are similar, which substantiates that the effect of
probiotic bacteria on iron absorption is due to the molecules
excreted by these bacteria.
HPLA is less effective in assisting enterocytes with iron absorp-
tion than the bacterial broth or its supernatant liquid. However,
higher HPLA concentrations (360 lM) result in more absorption.
Iron concentrations decrease from approximately 350 lM (Fig. 6,
columns 2) to 231 and 211 lM after 30 and 300 min of incubation,
respectively. While the higher concentration of HPLA (360 lM)
increases enterocyte iron uptake by about 40%, the increase for
the lower HPLA concentration (36 lM) is only about 30%.
Though HPLA clearly increases enterocyte iron absorption, the
higher quantities of enterocyte iron absorption by L. fermentum
and its supernatant liquid with respect to HPLA suggest that other
molecules excreted by the probiotic bacteria must also be involved
in this complex process. Lactic acid is a likely candidate, since L.
fermentum is defined as a lactic bacterium that excretes this
molecule while proliferating.
Fig. 5. Ferric-reducing activity at pH 3.5 of HPLA, lactic acid (LA), p-methylphenol (p-mPh) and the mixture of LA and p-mPh at different times. A: Fe(III) is in default with
respect to reducing molecules. B: Fe(III) is in excess with respect to the reducing molecules. The %Fe(III) reduction is referred to the concentration of Fe(III) (A) or the reducing
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Fig. 6. Fe(III) (367 lM) was incubated with enterocyte cells IEC-6 in the presence of
HPLA at 36 lM (columns 3), 360 lM (columns 4), L. fermentum (columns 5) and the
supernatant liquid obtained after centrifugation of L. fermentum (columns 6). Fe
concentrations in the solutions were measured by ICP-OES after 30 (black) and 300
min (white). Columns 1 corresponds to the initial Fe(III) solutions; columns 2
corresponds to Fe(III) after incubation with IEC-6 (control) and columns 7 data to
the plates only containing cells (control). Error bars, ± SD.
A. González et al. / Food Chemistry 228 (2017) 374–380 379Therefore, HPLA exhibits extraordinary ferric-reducing activity
and increases enterocyte iron uptake. Taking into account entero-
cytes in the duodenum and the participation of the ferric-
reducing protein DcytB (Lane et al., 2015; McKie, 2008), our results
point to a mechanism of iron absorption in which HPLA would act
similarly to DcytB by facilitating Fe(III) reduction in the stomach
and ultimately promoting Fe(II) uptake by DMT1 channels.
4. Conclusions
L. fermentum, one of the main probiotics of the microbiota, exhi-
bits an extraordinary ferric-reducing activity. This activity is
mainly due to one of the molecules excreted by this bacterium:
p-hydroxyphenyllactic acid (HPLA). HPLA effectively reduces
Fe(III) to Fe(II) and in the gastroinstestinal tract can mimic the
functionality of the DcytB ferric-reducing protein by promoting
iron uptake by enterocytes. We have demonstrated that the
increase of iron absorption in the presence of probiotic bacteria
is related to the ferric-reducing activity of excreted molecules.
380 A. González et al. / Food Chemistry 228 (2017) 374–380These results are a huge step towards solving the enigma of why
probiotic bacteria increase iron absorption. This discovery opens
new avenues for the treatment of human iron deficiency, one of
the most common and widespread nutritional disorders in the
world.
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